SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000897423-19-000028
Filing Date
2019-02-13
Accepted
2019-02-13 16:31:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 AQUESTIVE THERAPEUTICS, INC. SCHEDULE 13G STATEMENT aquestive13gfeb2019.htm SC 13G 96182
  Complete submission text file 0000897423-19-000028.txt   97494
Mailing Address 201 MAIN STREET SUITE 1900 FORT WORTH TX 76102
Business Address
BRATTON DOUGLAS K (Filed by) CIK: 0001281933 (see all company filings)

Type: SC 13G

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Subject) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90885 | Film No.: 19597759
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1